Thrombosis-Associated Risk Factors in Pediatrics and Adults Treated with Asparaginase-Containing Chemotherapy for ALL: A Systematic Review and Meta-Analysis
Jack T. Seki, Eshetu G. Atenafu, Hassan Sibai · 2026
Read Thrombosis-Associated Risk Factors in Pediatrics and Adults Treated with Asparaginase-Containing Chemotherapy for ALL: A Systematic Review and Meta-Analysis by Jack T. Seki, Eshetu G. Atenafu, Hassan Sibai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13297999.txt.
Description
Blood clots complicate a key leukemia drug family, and Jack T Seki with co-authors pooled the evidence on who is at risk in a 2026 systematic review and meta-analysis. Asparaginase-based chemotherapy for acute lymphoblastic leukemia can trigger thrombosis in children and adults alike, at rates that vary widely between reports.
Risk clustered around leukemia subtype, older age, treatment phase, and other clinical features the analysis identified. Newer agents such as cal-asparaginase pegol are spreading as older supplies shrink, making the risk picture more urgent. The authors strongly back preventive steps for patients carrying several risk factors, including heparin-type blood thinners or antithrombin replacement where these can be given safely.
Catalog record
| CREATOR | Jack T. Seki, Eshetu G. Atenafu, Hassan Sibai |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39901 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |